Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Glycerol Phenylbutyrate (Ravicti™) as a Chaperone to Stabilize Enzyme in Patients With MCAD Deficiency Due to the Common MCAD 985A>G (K304E) Mutation

NCT01881984 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT01881984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01881984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Glycerol Phenylbutyrate (Ravicti™) as a Chaperone to Stabilize Enzyme in Patients With MCAD Deficiency Due to the Common MCAD 985A>G (K304E) Mutation
Lead sponsor
University of Pittsburgh
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2013
Completion date
February 29, 2016
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

medium-chain acyl-coa dehydrogenase (mcad) deficiency